Back to results
US 11,027,014 B2Granted
Methods using GDF-15 antibodies for treatment of pulmonary arterial hypertension
AssigneeThe Brigham and Women's Hospital, Inc.
InventorsLai-Ming Yung, Paul B. Yu
Life of this patent
Estimating the term…
Abstract
The technology described herein is directed to methods and compositions for the treatment of hypertension, e.g. pulmonary arterial hypertension, relating to inhibition of TGFβ1, TGFβ3, and/or GDF-15.
Claims3
A method of treating pulmonary arterial hypertension (PAH) in a subject in need of treatment thereof, the method comprising administering a neutralizing antibody against Growth Differentiation Factor 15 (GDF-15) to the subject.
Dependencies are inferred from the claim text.